Gildan Activewear

GIL · TORONTO

$40.50−$0.53 (−1.29%)TodayMarket closed · Oct 23, 7:30 PM ET

Prev close $41.03

GIL analyst rating

BuyConsensus of 6 analysts over the last 12 months. 100% rate it a buy.

Strong buy0
Buy6
Hold0
Underperform0
Sell0

12-month price target · 10 analysts

Average $53.93 (+33.2% upside)

Low: $44.19
Now: $40.50
High: $62.09

Upgrades and downgrades

The latest rating actions, newest first

GIL analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
RBC Capital	Oct 20, 2026	Maintains	Outperform	$82.00 → $70.00	43%
UBS	Oct 15, 2026	Maintains	Buy	$111.00 → $71.00	50%
TD Securities	Sep 24, 2026	Maintains	Buy	$80.00 → $54.00	56%
UBS	Jul 31, 2026	Maintains	Buy	$110.00 → $111.00	50%
RBC Capital	Jul 31, 2026	Maintains	Outperform	$78.00 → $82.00	43%
Scotiabank	Jul 31, 2026	Maintains	Sector Outperform	$65.00 → $67.00	37%
Scotiabank	Jun 17, 2026	Maintains	Sector Outperform	$72.00 → $65.00	37%
Scotiabank	May 4, 2026	Maintains	Sector Outperform	$74.00 → $72.00	37%
Scotiabank	Mar 2, 2026	Maintains	Sector Outperform	$72.00 → $74.00	37%
RBC Capital	Mar 2, 2026	Maintains	Outperform	$79.00 → $78.00	43%

The case for and against

Updated Oct 22, 2026

Bull case

Gildan Activewear is viewed positively because its core thesis rests on durable free-cash-flow conversion, with historical operating cash flow above $500M for three consecutive years and FCF averaging about 50% of EBITDA since 2023. Management’s confidence in a return to organic growth in Q3/26, helped by completed destocking, new retail programs, and easier comparisons, supports the view that the business can rebound from the -8.7% decline in H1/26. The HanesBrands acquisition adds meaningful synergy potential, while trading at a near-trough 2027 P/E of 8.2x and with leverage near 3.3x PF LTM EBITDA, the setup offers upside if integration, de-levering, and eventual buybacks execute well.

Bear case

Gildan Activewear is facing a negative setup because sustained pressure on consumer discretionary spending and ongoing cost inflation are forcing lower revenue growth and margin assumptions through 2027, even as management must still prove a return to positive organic growth in H2/26. The business also carries meaningful execution and concentration risk after the Hanesbrands acquisition, while limited contract protection, rising DSOs, and weakening inventory turnover reduce visibility if customer demand softens. Although shares have already fallen -34% year-to-date to 7.8x FTM P/E, the valuation reset reflects real concern that earnings could still fall further under higher input costs, trade risk, and a prolonged macro slowdown.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.